Clinical Trial Update: Efficacy and Tolerability of the Combination of Valproic Acid and Lenalidomide in the Treatment of Patients With Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the combination of valproic acid and lenalidomide for myelodysplastic syndrome has been terminated; the update discusses efficacy and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Drugs mentioned

• Lenalidomide (lenalidomide)
• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: Heinrich-Heine University, Duesseldorf | Conditions: Myelodysplastic Syndrome MDS | Phase 2 | Status: TERMINATED